| Titre : | Professeur associé, Département de pharmacologie et physiologie, Faculté de médecine |
| Courriel : | jean.spenard@umontreal.ca |
Note importante :
Je ne suis plus impliqué dans la recherche. Je ne fais que de l’enseignement.
Formation
- B. Pharm. (1978), M.Sc. en Sciences pharmaceutiques (1981) et Doctorat en Pharmacologie (1984), Université de Montréal.
Thèmes de recherche
- En transition
Publications
- Heyman M, Kierkus J, Spenard J, Shbaklo H, Giguere M. Efficacy and safety of mesalamine suppositories for treatment of ulcerative proctitis in children and adolescents. Inflammatory Bowel Dis 2009. Publié en ligne, Mars 2010 in Wiley InterScience (www.interscience.wiley.com).
- Pereira SP, Ayaru L, Ackroyd R, Mitton D, Fullarton G, Zammit M, Grzebieniak Z, Messmann H, Ortner MA, Gao L, Trinh MM, Spénard J. Pharmacokinetics and safety of porfimer after repeated administrations 30 to 45 days apart to patients undergoing photodynamic therapy. Aliment Pharmacol Ther. 2010;32(6):821-7.
- Ratziu V, de Ledinghen V, Oberti F, Mathurin P, Wartelle-Bladou C, Renou C, Sogni P, Maynard M, Larrey D, Serfaty L, Bonnefont-Rousselot D, Bastard JP, Rivière M, Spénard J, on behalf of the FRESGUN. A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis. J Hepatol 2011;54:1011-1019.
- Konstan MW, Liou TG , Strausbaugh SD, Ahrens R, Kanga JF, Graff GR, Moffett K, Millard SL, Nasr SZ, Simeon E, Spenard J, Grondin J. Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic Fibrosis. Gastroenterol Res Pract Volume 2010, e-pub Article ID 898193, 7 pages.
- Haddad Y, Vallerand D, Brault A, Spenard J, Haddad PS. NCX 1000 Alone or in Combination with Vitamin E Reverses Experimental Nonalcoholic Steatohepatitis in the Rat Similarly to UDCA. Int J Hepatol Volume 2011, e-pub Article ID 136816, 12 pages.